Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
XieYHouWSongXYuYHuangJSunXet al
All information provided is for research and educational purposes only
En la actualidad, hay poca evidencia de que la colina diettica aumente el riesgo de eventos cardiovasculares
In February, based on early results of promising anti-tumor activity and manageable safety profile from a Phase I study, the FDA granted Fast Track Designation to CUSP06, a Cadherin-6 ADC employing exatecan as the payload, for the treatment of PROC
Recently, the compounding of weight-loss drugs has surged as Lilly and Novo have struggled to meet the high demand for their new medications
US$ 27.64
US$ 28.57
US$ 24.83
